The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 14th 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Triple Therapy With New Anticoagulants Suitable for Highest-Risk Patients
June 3rd 2013A literature review finds that triple therapy including newer anticoagulants, aspirin, and clopidogrel may increase the risk of bleeding and should be limited to patients at highest risk for thromboembolic events.
Read More